This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug (VVP)

This study has been completed.
Information provided by (Responsible Party):
Cook Group Incorporated Identifier:
First received: June 16, 2009
Last updated: December 29, 2015
Last verified: July 2012
This clinical trial will study the safety and effectiveness of the Biodesign Vesico-vaginal fistula plug in the treatment of vesico-vaginal fistulas resulting from childbirth trauma.

Condition Intervention
Vesico-vaginal Fistula Device: Surgisis Biodesign (Vesico-vaginal fistula plug)

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug

Resource links provided by NLM:

Further study details as provided by Cook Group Incorporated:

Primary Outcome Measures:
  • Fistula [ Time Frame: 4 months ]
  • Adverse Events [ Time Frame: 4 months ]

Secondary Outcome Measures:
  • Improvement in quality of life [ Time Frame: 4 months ]

Enrollment: 20
Study Start Date: September 2009
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Vesico-vaginal fistula plug
Vesico-vaginal fistula plug
Device: Surgisis Biodesign (Vesico-vaginal fistula plug)
Vesico-vaginal fistula plug
Other Name: SurgiSIS Biodesign


Ages Eligible for Study:   10 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient has signed and dated the informed consent.
  • Patient is 18 years old; or is an emancipated minor as defined by Ugandan law or is under 18 but has a parent/guardian who provides informed consent.
  • Patient agrees to follow-up schedule.
  • Patient presents with a leaking vesico-vaginal fistula, confirmed by exam, with no signs of acute inflammation, no signs of active urinary tract infection that cannot be controlled with a standard pre-operative course of antibiotics, no signs of vaginal infection, or no signs of abscess.
  • Patient presents with a fistula of a size and in a location that may be reasonably treated with the VVP device.

Exclusion Criteria:

  • Patient is not medically fit enough for surgery under general or spinal anesthesia.
  • Patient is a "mature minor" as defined by Ugandan law.
  • Patient is pregnant, breastfeeding or planning further pregnancy during the study period.
  • Patient has physical allergies or cultural objections to the receipt of porcine products.
  • Patient has an active sexually transmitted disease, is HIV-positive, or any other active systemic infection that may interfere with healing.
  • Patient has spina bifida or other neural tube defect.
  • Patient has interstitial cystitis or other chronic pelvic pain syndrome.
  • Patient has signs of acute or chronic pelvic inflammation, active urinary tract infection not responsive to antibiotic treatment, vaginal infection, or abscess of the fistula tract.
  • Patient presents with clinically diagnosed sepsis (for whatever reason).
  • Patient has concomitant ureterovaginal fistula.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00923338

Mbarara University Teaching Hospital
Mbarara, Uganda
Sponsors and Collaborators
Cook Group Incorporated
Principal Investigator: Musa Kayondo, MD Mbarara University Teaching Hospital
  More Information

Responsible Party: Cook Group Incorporated Identifier: NCT00923338     History of Changes
Other Study ID Numbers: 09-006
Study First Received: June 16, 2009
Last Updated: December 29, 2015

Keywords provided by Cook Group Incorporated:
vesico-vaginal fistula

Additional relevant MeSH terms:
Vaginal Fistula
Vesicovaginal Fistula
Pathological Conditions, Anatomical
Vaginal Diseases
Genital Diseases, Female
Urinary Bladder Fistula
Urinary Fistula
Urogenital Abnormalities
Urinary Bladder Diseases
Urologic Diseases processed this record on September 21, 2017